chrX-106820880-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_017752.3(TBC1D8B):c.245C>A(p.Ala82Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00000688 in 1,163,343 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.0000057 ( 0 hom. 3 hem. )
Consequence
TBC1D8B
NM_017752.3 missense
NM_017752.3 missense
Scores
1
4
12
Clinical Significance
Conservation
PhyloP100: 4.00
Genes affected
TBC1D8B (HGNC:24715): (TBC1 domain family member 8B) This gene encodes a protein with a TBC (Tre-2/Bub2/CDC16) domain. Some mammalian proteins with this domain have been shown to function as Rab-GAPs by binding to specific Rab proteins and affecting their GTPase activity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]
MORC4 (HGNC:23485): (MORC family CW-type zinc finger 4) In human, the four current members of the microrchidia (morc) gene family share an N-terminal ATPase-like ATP-binding region and a CW four-cysteine zinc-finger motif. The protein encoded by this gene also has a nuclear matrix binding domain and a two-stranded coiled-coil motif near its C-terminus. This gene is widely expressed at low levels in normal tissues and has elevated expression in placenta and testis. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.09587476).
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBC1D8B | NM_017752.3 | c.245C>A | p.Ala82Asp | missense_variant | 3/21 | ENST00000357242.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBC1D8B | ENST00000357242.10 | c.245C>A | p.Ala82Asp | missense_variant | 3/21 | 1 | NM_017752.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111183Hom.: 0 Cov.: 23 AF XY: 0.0000298 AC XY: 1AN XY: 33591
GnomAD3 genomes
AF:
AC:
2
AN:
111183
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33591
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000570 AC: 6AN: 1052108Hom.: 0 Cov.: 22 AF XY: 0.00000908 AC XY: 3AN XY: 330218
GnomAD4 exome
AF:
AC:
6
AN:
1052108
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
330218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111235Hom.: 0 Cov.: 23 AF XY: 0.0000297 AC XY: 1AN XY: 33653
GnomAD4 genome
AF:
AC:
2
AN:
111235
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33653
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Nephrotic syndrome, type 20 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant c.245C>A (p.Ala82Asp) in TBC1D8B gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Ala82Asp variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. The amino acid Ala at position 82 is changed to a Asp changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted to be damaging by both SIFT and PolyPhen2. The residue is conserved across species. The amino acid change p.Ala82Asp in TBC1D8B is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;D;D;N
REVEL
Benign
Sift
Benign
D;T;T;T
Sift4G
Benign
T;T;D;T
Polyphen
D;.;D;.
Vest4
MutPred
Gain of solvent accessibility (P = 0.0202);Gain of solvent accessibility (P = 0.0202);Gain of solvent accessibility (P = 0.0202);Gain of solvent accessibility (P = 0.0202);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at